英国生物技术发现有毒的血液外生物与ALS有关,正在研制治疗和早期检测试验。 UK biotech finds toxic blood exosomes linked to ALS, developing treatment and early-detection test.

联合王国生物技术Vesalic有限公司揭示了将ALS与系统性代谢机能障碍联系起来的一个突破,查明了血液中具有异常脂质的有毒外生物,从而损害神经元。 UK biotech Vesalic Limited has revealed a breakthrough linking ALS to a systemic metabolic dysfunction, identifying toxic exosomes with abnormal lipids in the blood that damage neurons. 该公司正在开发一种消除这些毒素的疗法,目前正在进行临床前期研究,并计划进行2027年临床试验。 The company is developing a therapy to neutralize these toxins, with preclinical studies ongoing and a 2027 clinical trial filing planned. 它还通过发现外体细胞的独特脂质变化,创造了一种血液检测,可以检测出ALS,准确度超过90%,从而能够早期诊断和治疗监测. It also created a blood test detecting ALS with over 90% accuracy by spotting unique lipid changes in exosomes, enabling early diagnosis and treatment monitoring. 该平台正在扩展到阿尔茨海默氏病和帕金森病。 The platform is being expanded to Alzheimer’s and Parkinson’s disease.